Insurers are Still Denying Treatments for Pre-Existing Conditions” perfectly reflects the drug lobby’s criticism of the clinical safeguards used to protect patients from opioid abuse.

Under the guise of criticizing “obstacles” to care, the writer denounces the tools medical professionals use to save lives and reduce wasteful spending. These include starting patients on less addictive medicines and curbing the number of opioids per prescription. Such utilization management strategies are widely accepted in the health care community as essential in the fight against abuse.

The opioid epidemic is the leading killer of Americans under the age of 50. By attacking the tools that help prevent overdoses, the writer comes off as little more than a shill for the $10 billion per year opioid industry.